Looking at both sides of the coin, Bravura was overvalued above $6, just as most would consider it undervalued below $2. Whether I am right or wrong about Bravura and its fair value is up for debate.
What I can say for certain is I don't think you have any idea about your reasoning for them being a poor investment choice. 3 years ago everyone thought Bravura was a great company, analysts included - what fundamentals have changed?
Do you do any credible research when you bag stocks? All I see you do is spew negativity and berate companies on HC that you don't hold - it seems to me that you thrive off the negativity.
- Forums
- ASX - By Stock
- BVS
- Ann: CFO Transition
Ann: CFO Transition, page-68
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BVS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.54 |
Change
0.000(0.00%) |
Mkt cap ! $688.2M |
Open | High | Low | Value | Volume |
$1.54 | $1.55 | $1.51 | $1.061M | 693.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4 | $1.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.54 | 124 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4 | 1.535 |
1 | 277 | 1.530 |
2 | 15270 | 1.525 |
1 | 5270 | 1.520 |
1 | 1345 | 1.510 |
Price($) | Vol. | No. |
---|---|---|
1.540 | 124 | 1 |
1.545 | 6472 | 1 |
1.550 | 56446 | 3 |
1.555 | 5270 | 1 |
1.560 | 26262 | 2 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online